Covered recipient · General Payments record
JAMES S MANTON
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$1,627.36
- Reported across 92 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $468.00 | 24 |
| Education | $17.73 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $259.81 | 15 |
| Celltrion USA Inc. | $62.99 | 3 |
| Enterra Medical, Inc. | $47.00 | 1 |
| PFIZER INC. | $39.63 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $30.66 | 2 |
| Merck Sharp & Dohme Corporation | $28.35 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.29 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.57 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961330 | CMS |
| ABBVIE INC. | $14.95 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961332 | CMS |
| ABBVIE INC. | $15.97 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961334 | CMS |
| ABBVIE INC. | $20.54 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961336 | CMS |
| ABBVIE INC. | $17.82 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961338 | CMS |
| ABBVIE INC. | $15.73 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961340 | CMS |
| ABBVIE INC. | $22.48 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961342 | CMS |
| ABBVIE INC. | $20.79 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961344 | CMS |
| ABBVIE INC. | $8.81 | 07/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961346 | CMS |
| ABBVIE INC. | $25.11 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961348 | CMS |
| ABBVIE INC. | $24.37 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961350 | CMS |
| ABBVIE INC. | $17.23 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961352 | CMS |
| ABBVIE INC. | $17.51 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961354 | CMS |
| ABBVIE INC. | $13.87 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961356 | CMS |
| ABBVIE INC. | $5.06 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104961358 | CMS |
| Celltrion USA Inc. | $17.73 | 09/12/2024 | Education | Undisputed | 01/23/2026 | 1075854865 | CMS |
| Celltrion USA Inc. | $26.20 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075854867 | CMS |
| Celltrion USA Inc. | $19.06 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1075854869 | CMS |
| Enterra Medical, Inc. | $47.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154810330 | CMS |
| Merck Sharp & Dohme LLC | $28.35 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141798223 | CMS |
| PFIZER INC. | $18.69 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131743334 | CMS |
| PFIZER INC. | $20.94 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131869404 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.54 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153685019 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.12 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153534814 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.29 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137629296 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.